{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:59:21Z","timestamp":1784210361775,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":290,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MRC CiC"],"award-info":[{"award-number":["MRC CiC"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010757","name":"National Centre for the Replacement Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","award":["Training grant"],"award-info":[{"award-number":["Training grant"]}],"id":[{"id":"10.13039\/501100010757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008304","name":"Department of Education, Northern Ireland","doi-asserted-by":"publisher","award":["Ph.D. grant"],"award-info":[{"award-number":["Ph.D. grant"]}],"id":[{"id":"10.13039\/100008304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1074\/jbc.ac119.010148","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T21:45:17Z","timestamp":1570830317000},"page":"18041-18045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-7826","authenticated-orcid":false,"given":"Louise R.","family":"Dutton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold J.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1375-1076","authenticated-orcid":false,"given":"Derek P.","family":"Brazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.AC119.010148_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20100305","article-title":"Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists","volume":"429","author":"Rider","year":"2010","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.AC119.010148_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcb.2014.12.004","article-title":"BMP signalling: agony and antagony in the family","volume":"25","author":"Brazil","year":"2015","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.AC119.010148_bib3","doi-asserted-by":"crossref","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","article-title":"Bone morphogenetic proteins","volume":"8","author":"Katagiri","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1074\/jbc.AC119.010148_bib4","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1185\/030079906X80576","article-title":"Bone morphogenetic protein signal transduction in bone","volume":"22","author":"ten Dijke","year":"2006","journal-title":"Curr. Med. Res. Opin"},{"key":"10.1074\/jbc.AC119.010148_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1178","article-title":"Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning","volume":"34","author":"Khokha","year":"2003","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.AC119.010148_bib6","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1242\/dev.01251","article-title":"Gremlin-mediated BMP antagonism induces theepithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis","volume":"131","author":"Michos","year":"2004","journal-title":"Development"},{"key":"10.1074\/jbc.AC119.010148_bib7","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1242\/dev.02861","article-title":"Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF\/WNT11 feedback signalling during kidney branching morphogenesis","volume":"134","author":"Michos","year":"2007","journal-title":"Development"},{"key":"10.1074\/jbc.AC119.010148_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/j.ajkd.2005.03.014","article-title":"Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy","volume":"45","author":"Dolan","year":"2005","journal-title":"Am. J. Kidney Dis"},{"key":"10.1074\/jbc.AC119.010148_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbadis.2007.09.005","article-title":"Co-regulation of Gremlin and Notch signalling in diabetic nephropathy","volume":"1782","author":"Walsh","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.AC119.010148_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2009.03.086","article-title":"Bone morphogenetic protein-7 and Gremlin: new emerging therapeutic targets for diabetic nephropathy","volume":"383","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.AC119.010148_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.111.038125","article-title":"Gremlin plays a key role in the pathogenesis of pulmonary hypertension","volume":"125","author":"Cahill","year":"2012","journal-title":"Circulation"},{"key":"10.1074\/jbc.AC119.010148_bib12","doi-asserted-by":"crossref","first-page":"L272","DOI":"10.1152\/ajplung.00358.2007","article-title":"Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension","volume":"295","author":"Costello","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol"},{"key":"10.1074\/jbc.AC119.010148_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.ajpath.2013.07.017","article-title":"Treatment with anti-Gremlin 1 antibody ameliorates chronic hypoxia\/SU5416\u2013induced pulmonary arterial hypertension in mice","volume":"183","author":"Ciuclan","year":"2013","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.AC119.010148_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00109-015-1308-9","article-title":"Gremlin is a key pro-fibrogenic factor in chronic pancreatitis","volume":"93","author":"Staloch","year":"2015","journal-title":"J. Mol. Med"},{"key":"10.1074\/jbc.AC119.010148_bib15","first-page":"58","article-title":"The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol. Rep"},{"key":"10.1074\/jbc.AC119.010148_bib16","doi-asserted-by":"crossref","first-page":"98280","DOI":"10.18632\/oncotarget.21550","article-title":"Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma","volume":"8","author":"Yin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.AC119.010148_bib17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1101\/gad.235515.113","article-title":"Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy","volume":"28","author":"Yan","year":"2014","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.AC119.010148_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molonc.2013.04.002","article-title":"Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1","volume":"7","author":"Karagiannis","year":"2013","journal-title":"Mol. Oncol"},{"key":"10.1074\/jbc.AC119.010148_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.celrep.2014.07.020","article-title":"A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding","volume":"8","author":"Lewis","year":"2014","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.AC119.010148_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/hsz-2014-0221","article-title":"Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression","volume":"396","author":"Karagiannis","year":"2015","journal-title":"Biol. Chem"},{"key":"10.1074\/jbc.AC119.010148_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3750","article-title":"Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche","volume":"21","author":"Davis","year":"2015","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.AC119.010148_bib22","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.173.10.5914","article-title":"Cutting edge: bone morphogenetic protein antagonists Drm\/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis","volume":"173","author":"Chen","year":"2004","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.AC119.010148_bib23","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1074\/jbc.M117.804021","article-title":"Identification of direct negative crosstalk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways","volume":"293","author":"Tumelty","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.AC119.010148_bib24","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/oncsis.2013.29","article-title":"Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug","volume":"2","author":"Tamminen","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1074\/jbc.AC119.010148_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2006-06-032276","article-title":"Bone morphogenic protein antagonist Drm\/gremlin is a novel proangiogenic factor","volume":"109","author":"Stabile","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.AC119.010148_bib26","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Mitola","year":"2010","journal-title":"Blood"},{"key":"10.1074\/jbc.AC119.010148_bib27","doi-asserted-by":"crossref","first-page":"e1004158","DOI":"10.1371\/journal.pcbi.1004158","article-title":"Site-specific phosphorylation of VEGFR2 is mediated by receptor trafficking: insights from a computational model","volume":"11","author":"Clegg","year":"2015","journal-title":"PLoS Comput. Biol"},{"key":"10.1074\/jbc.AC119.010148_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10456-012-9309-6","article-title":"Involvement of \u03b1v\u03b23 integrin in gremlin-induced angiogenesis","volume":"16","author":"Ravelli","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1074\/jbc.AC119.010148_bib29","doi-asserted-by":"crossref","first-page":"35353","DOI":"10.18632\/oncotarget.9286","article-title":"Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist","volume":"7","author":"Grillo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.AC119.010148_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.18632\/oncotarget.13518","article-title":"Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.AC119.010148_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fphar.2018.01195","article-title":"Gremlin regulates tubular epithelial to mesenchymal transition via VEGFR2: potential role in renal fibrosis","volume":"9","author":"Marquez-Exposito","year":"2018","journal-title":"Front. Pharmacol"},{"key":"10.1074\/jbc.AC119.010148_bib32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/CS20171553","article-title":"Gremlin activates the Notch pathway linked to renal inflammation","volume":"132","author":"Lavoz","year":"2018","journal-title":"Clin. Sci"},{"key":"10.1074\/jbc.AC119.010148_bib33","doi-asserted-by":"crossref","first-page":"84748","DOI":"10.18632\/oncotarget.12454","article-title":"Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling","volume":"7","author":"Ji","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.AC119.010148_bib34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl. Med"},{"key":"10.1074\/jbc.AC119.010148_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.humpath.2016.12.018","article-title":"Prognostic significance of stromal GREM1 expression in colorectal cancer","volume":"62","author":"Jang","year":"2017","journal-title":"Hum. Pathol"},{"key":"10.1074\/jbc.AC119.010148_bib36","doi-asserted-by":"crossref","first-page":"F1141","DOI":"10.1152\/ajprenal.00344.2016","article-title":"Gremlin1 plays a key role in kidney development and renal fibrosis","volume":"312","author":"Church","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.AC119.010148_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3899\/jrheum.150523","article-title":"GREM1 is a key regulator of synoviocyte hyperplasia and invasiveness","volume":"43","author":"Han","year":"2016","journal-title":"J. Rheumatol"},{"key":"10.1074\/jbc.AC119.010148_bib38","doi-asserted-by":"crossref","first-page":"61318","DOI":"10.18632\/oncotarget.18095","article-title":"A functional variant in GREM1 confers risk for colorectal cancer by disrupting a hsa-miR-185\u20133p binding site","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.AC119.010148_bib39","doi-asserted-by":"crossref","first-page":"802841","DOI":"10.1155\/2014\/802841","article-title":"Gremlin activates the Smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells","volume":"2014","author":"Rodrigues-Diez","year":"2014","journal-title":"Biomed. Res. Int"},{"key":"10.1074\/jbc.AC119.010148_bib40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","article-title":"Pathophysiological consequences of VEGF-induced vascular permeability","volume":"437","author":"Weis","year":"2005","journal-title":"Nature"},{"key":"10.1074\/jbc.AC119.010148_bib41","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1074\/jbc.273.24.15099","article-title":"Vascular permeability factor\/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins","volume":"273","author":"Kevil","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.AC119.010148_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1096\/fj.02-0484fje","article-title":"VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor","volume":"17","author":"Behzadian","year":"2003","journal-title":"FASEB J"},{"key":"10.1074\/jbc.AC119.010148_bib43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.ASN.0000115397.22519.03","article-title":"Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties","volume":"15","author":"Satchell","year":"2004","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.AC119.010148_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.devcel.2011.11.002","article-title":"VEGF-induced vascular permeability is mediated by FAK","volume":"22","author":"Chen","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.AC119.010148_bib45","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.09-4951","article-title":"Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy","volume":"51","author":"Medina","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.AC119.010148_bib46","article-title":"Gremlin1 blocks vascular endothelial growth factor signalling in the pulmonary microvascular endothelium","author":"Rowan","year":"2018","journal-title":"Pulm. Circ"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820306712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820306712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.AC119.010148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:09:47Z","timestamp":1641269387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820306712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":46,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0021925820306712"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ac119.010148","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.AC119.010148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Dutton et al.","name":"copyright","label":"Copyright"}]}}